Quantcast

Latest Pemetrexed Stories

2014-09-08 23:07:55

Researchers say certain factors appear to improve the odds of surviving mesothelioma, regardless of what type of treatment a patient has. Raleigh, NC (PRWEB) September 08, 2014 Scientists in Australia have found that longer survival with mesothelioma is not always linked to specific types of treatments. Surviving Mesothelioma has just posted details of the new study. Click here to read the full story. A study conducted by the Asbestos Diseases Research Institute on 910 asbestos-exposed...

2014-08-20 23:02:19

New research report “Non-Small Cell Lung Cancer Market to 2020 - New Therapies to Enhance Treatment Segmentation and Drive Growth in an Increasingly Competitive Market” elaborated by GBI Research is now available at MarketPublishers.com. According to the study, the NSCLC Market in top 8 developed nations is predicted to see a 6.6% CAGR through 2020. London, UK (PRWEB) August 20, 2014 The non-small cell lung cancer (NSCLC) market value is expected to increase considerably in the offing...

2014-08-15 23:07:08

Simvastatin Could Boost Effectiveness of Chemotherapy Drug Pemetrexed DALLAS (PRWEB) August 15, 2014 A team of Korean researchers has found that a drug normally used to lower cholesterol could also help a commonly used chemotherapy medication kill malignant mesothelioma cells, the mesothelioma law firm of Baron and Budd reports. The results of the research team’s work was published in the latest issue of the International Journal of Oncology....

2014-07-30 23:07:39

The executive director of the Mesothelioma Applied Research Foundation, Mary Hesdorffer, APRN, was featured as a speaker during a Verastem, Inc. investor meeting to bring attention to mesothelioma and the need for clinical trials to advance and to increase the number therapeutic options for mesothelioma patients. Alexandria, VA (PRWEB) July 30, 2014 On July 10, during the research and development portion of the Verastem, Inc.’s investor meeting, Mary Hesdorffer, APRN, the executive...

2014-07-16 23:08:14

Researchers say pemetrexed (Alimta), the top chemotherapy drug for mesothelioma, may carry a risk of acute kidney injury, even in patients whose baseline kidney function falls within recommended limits. Raleigh, NC (PRWEB) July 16, 2014 Italian scientists say patients on the popular mesothelioma drug pemetrexed may need to take certain precautions to avoid damaging their kidneys. An article on the new research has just been published on the Surviving Mesothelioma website. Click here to...

2014-07-11 23:05:26

Scientists say slight inherited differences in the genes may help predict how mesothelioma patients will respond to chemotherapy. Raleigh, NC (PRWEB) July 11, 2014 Cancer researchers in Slovenia say genetic variations called polymorphisms appear to have a significant impact on how patients respond to treatment with pemetrexed (Alimta), the most popular chemotherapy drug for mesothelioma. Surviving Mesothelioma has the full story. Click here to read the new post now. Researchers at the...

2014-07-08 23:09:40

Top mesothelioma researchers say an immunotoxin may have the power to significantly improve the effectiveness of chemotherapy in patients with malignant pleura mesothelioma. Raleigh, NC (PRWEB) July 08, 2014 According to a new NIH research study, more than three quarters of mesothelioma patients responded to chemotherapy when they were also given the anti-mesothelin immunotoxin SS1P. Click here to read Surviving Mesothelioma’s newly-posted article on how this important study may impact...

2014-07-07 23:05:15

Researchers say some patients on the popular mesothelioma drug, pemetrexed, may be able to avoid the risks and discomfort of lung fluid evacuation. Raleigh, NC (PRWEB) July 07, 2014 A new Danish study suggests that the practice of draining off lung fluid to avoid pemetrexed (Alimta) toxicity may not be necessary for all patients. Surviving Mesothelioma has just posted details of the new study for mesothelioma patients and their families. Click here to read it now. Researchers at the...

2014-06-30 23:16:32

There is new evidence that second-line chemotherapy with a drug called gemcitabine can significantly prolong survival in people with malignant pleural mesothelioma. Raleigh, NC (PRWEB) June 30, 2014 A new study out of Turkey finds that mesothelioma patients who have second-line chemotherapy with the antimetabolite, gemcitabine (Gemzar) had a median survival rate 8 months longer than those who had only first-line chemotherapy. Surviving Mesothelioma has just posted a report on the new...

2014-06-20 23:06:04

Italian researchers say a treatment made from a human protein can help improve the effectiveness of chemotherapy for patients fighting malignant pleural mesothelioma. Raleigh, NC (PRWEB) June 20, 2014 A team of cancer doctors says the combination of a lab-created compound based on a human protein and traditional chemotherapy drugs can help shrink mesothelioma tumors better than either treatment alone. Surviving Mesothelioma has just posted an article on the new research. Click here to...


Word of the Day
virgule
  • A punctuation mark (/) used to separate related items of information.
  • A little rod; a twig.
This word comes from the Late Latin 'virgula,' accentual mark, a diminutive of 'virga,' rod.
Related